Scientists at Sanford Burnham Prebys Medical Discovery Institute have identified a drug candidate that blocks the uptake of glutamine, a key food source for many tumors, and slows the growth of melanoma. The drug is a small ...
Mar 19, 2021
0
113
Scientists at Sanford Burnham Prebys Medical Discovery Institute demonstrated for the first time that blocking 'cell drinking,' or macropinocytosis, in the thick tissue surrounding a pancreatic tumor slowed tumor growth—providing ...
Mar 17, 2021
0
76
US manufacturer Moderna on Tuesday said it has started COVID-19 vaccine trials for children aged from 6 months to under 12 years old, with plans to enroll about 6,750 participants.
Mar 16, 2021
0
8
The European Union's drug regulator insisted Tuesday that there is "no indication" the AstraZeneca vaccine causes blood clots as governments around the world faced the grimmest of dilemmas: push on with a vaccine known to ...
Mar 16, 2021
0
3
A new SARS-CoV-2 vaccine candidate, developed by giving a key protein's gene a ride into the body while encased in a measles vaccine, has been shown to produce a strong immune response and prevent SARS-CoV-2 infection and ...
Mar 10, 2021
0
267
Dear Healthy Men: A few weeks ago, you did a column on how short men face discrimination when compared to taller men. I'm wondering whether the same kind of thing applies to men who are overweight or obese.
Mar 9, 2021
2
0
Researchers from Cleveland Clinic's Global Center for Pathogen Research & Human Health have developed a promising new COVID-19 vaccine candidate that utilizes nanotechnology and has shown strong efficacy in preclinical disease ...
Mar 2, 2021
0
7
US biotech firm Moderna said Wednesday that doses of its new COVID-19 vaccine candidate aimed at the South African coronavirus variant had been shipped to the US National Institutes of Health for testing.
Feb 24, 2021
0
5
In a time of extreme political polarization, hearing that a political candidate has taken a stance inconsistent with their party might raise some questions for their constituents.
Feb 22, 2021
0
4
The Altimmune Inc. vaccine candidate that was tested preclinically at the University of Alabama at Birmingham last year is expected to start patient enrollment for its Phase 1 clinical trial next week.
Feb 19, 2021
0
13
